290 related articles for article (PubMed ID: 27588731)
21. The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry.
Weimar C; Diener HC; Alberts MJ; Steg PG; Bhatt DL; Wilson PW; Mas JL; Röther J;
Stroke; 2009 Feb; 40(2):350-4. PubMed ID: 19023098
[TBL] [Abstract][Full Text] [Related]
22. Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack.
Minematsu K; Ikeda T; Ogawa S; Kitazono T; Nakagawara J; Miyamoto S; Murakawa Y; Takeichi M; Kidani Y; Okayama Y; Sunaya T; Sato S; Yamanaka S
Cerebrovasc Dis; 2019; 48(1-2):53-60. PubMed ID: 31578012
[TBL] [Abstract][Full Text] [Related]
23. Predictors of recurrent stroke after percutaneous closure of patent foramen ovale.
Rudolph V; Augustin J; Hofmann T; Hamm CW; Meinertz T; Köster R; Baldus S; Franzen O
EuroIntervention; 2014; 9(12):1418-22. PubMed ID: 24169021
[TBL] [Abstract][Full Text] [Related]
24. A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease.
Ducrocq G; Amarenco P; Labreuche J; Alberts MJ; Mas JL; Ohman EM; Goto S; Lavallée P; Bhatt DL; Steg PG
Circulation; 2013 Feb; 127(6):730-8. PubMed ID: 23277306
[TBL] [Abstract][Full Text] [Related]
25. Trends and predictors of myocardial infarction or vascular death after ischaemic stroke or TIA in China, 2007-2018: insights from China National Stroke Registries.
Li L; Pan Y; Wang M; Jing J; Meng X; Jiang Y; Guo C; Jin Z; Wang Y
Stroke Vasc Neurol; 2021 Jun; 6(2):214-221. PubMed ID: 33127855
[TBL] [Abstract][Full Text] [Related]
26. Long term risks of stroke, myocardial infarction, and vascular death in "low risk" patients with a non-recent transient ischaemic attack.
Clark TG; Murphy MF; Rothwell PM
J Neurol Neurosurg Psychiatry; 2003 May; 74(5):577-80. PubMed ID: 12700296
[TBL] [Abstract][Full Text] [Related]
27. Aspirin and the risk of cardiovascular events in atherosclerosis patients with and without prior ischemic events.
Bavry AA; Elgendy IY; Elbez Y; Mahmoud AN; Sorbets E; Steg PG; Bhatt DL;
Clin Cardiol; 2017 Sep; 40(9):732-739. PubMed ID: 28520215
[TBL] [Abstract][Full Text] [Related]
28. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.
Bhatt DL; Eagle KA; Ohman EM; Hirsch AT; Goto S; Mahoney EM; Wilson PW; Alberts MJ; D'Agostino R; Liau CS; Mas JL; Röther J; Smith SC; Salette G; Contant CF; Massaro JM; Steg PG;
JAMA; 2010 Sep; 304(12):1350-7. PubMed ID: 20805624
[TBL] [Abstract][Full Text] [Related]
29. Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients.
Delgado P; Chacón P; Penalba A; Pelegri D; García-Berrocoso T; Giralt D; Santamarina E; Ribó M; Maisterra O; Alvarez-Sabín J; Rosell A; Montaner J
Cerebrovasc Dis; 2012; 33(2):150-8. PubMed ID: 22178747
[TBL] [Abstract][Full Text] [Related]
30. Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population.
Sverre E; Peersen K; Weedon-Fekjær H; Perk J; Gjertsen E; Husebye E; Gullestad L; Dammen T; Otterstad JE; Munkhaugen J
BMC Cardiovasc Disord; 2020 Feb; 20(1):61. PubMed ID: 32024471
[TBL] [Abstract][Full Text] [Related]
31. Burden of Premature Atrial Complexes and Risk of Recurrent Stroke and Death in Patients with Mild to Moderate Ischemic Stroke.
Sejr MH; May O; Damgaard D; Bruun NH; Nielsen JC
J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104490. PubMed ID: 31839547
[TBL] [Abstract][Full Text] [Related]
32. Secondary prophylactic treatment and long-term prognosis after TIA and different subtypes of stroke. A 25-year follow-up hospital-based observational study.
Eriksson SE
Brain Behav; 2017 Jan; 7(1):e00603. PubMed ID: 28127521
[TBL] [Abstract][Full Text] [Related]
33. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
[TBL] [Abstract][Full Text] [Related]
34. Risk of Ischemic Stroke and Transient Ischemic Attack Is Increased up to 90 Days after Non-Carotid and Non-Cardiac Surgery.
Grau AJ; Eicke M; Burmeister C; Hardt R; Schmitt E; Dienlin S
Cerebrovasc Dis; 2017; 43(5-6):242-249. PubMed ID: 28241134
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack: Results from TRA 2°P-TIMI 50.
Bohula EA; Aylward PE; Bonaca MP; Corbalan RL; Kiss RG; Murphy SA; Scirica BM; White H; Braunwald E; Morrow DA
Circulation; 2015 Nov; 132(20):1871-9. PubMed ID: 26338971
[TBL] [Abstract][Full Text] [Related]
36. Stroke in Patients With Peripheral Artery Disease.
Kolls BJ; Sapp S; Rockhold FW; Jordan JD; Dombrowski KE; Fowkes FGR; Mahaffey KW; Berger JS; Katona BG; Blomster JI; Norgren L; Abramson BL; Leiva-Pons JL; Prieto JC; Sokurenko G; Hiatt WR; Jones WS; Patel MR
Stroke; 2019 Jun; 50(6):1356-1363. PubMed ID: 31092165
[TBL] [Abstract][Full Text] [Related]
37. PR interval prolongation in coronary patients or risk equivalent: excess risk of ischemic stroke and vascular pathophysiological insights.
Chan YH; Hai JJ; Lau KK; Li SW; Lau CP; Siu CW; Yiu KH; Tse HF
BMC Cardiovasc Disord; 2017 Aug; 17(1):233. PubMed ID: 28836952
[TBL] [Abstract][Full Text] [Related]
38. Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack) study population.
Fox K; Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Hennerici MG; Mattle HP; Rothwell PM;
Int J Cardiol; 2013 Oct; 168(4):3500-5. PubMed ID: 23706327
[TBL] [Abstract][Full Text] [Related]
39. History of transient ischaemic attack, myocardial infarction and hyperlipidaemia affects outcome following carotid artery stenting.
Macharzina RR; Claus C; Messé SR; Boehme T; Vach W; Winker T; Rastan A; Beschorner U; Noory E; Neumann FJ; Zeller T
EuroIntervention; 2015 Nov; 11(7):808-15. PubMed ID: 26603988
[TBL] [Abstract][Full Text] [Related]
40. Cerebrovascular accident complicating acute myocardial infarction: incidence, clinical significance and short- and long-term mortality rates. The SPRINT Study Group.
Behar S; Tanne D; Abinader E; Agmon J; Barzilai J; Friedman Y; Kaplinsky E; Kauli N; Kishon Y; Palant A
Am J Med; 1991 Jul; 91(1):45-50. PubMed ID: 1858828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
